miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
20 03 2021
Historique:
received: 19 02 2021
revised: 12 03 2021
accepted: 17 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 25 2 2023
Statut: epublish

Résumé

Epigenetic changes, including miRNAs deregulation, have been suggested to play a significant role in development of obliterative bronchiolitis (OB) in transplanted lungs. Many studies have tried to identify ideal candidate miRNAs and the downstream pathways implicated in the bronchiolar fibro-obliterative process. Several candidate miRNAs, previously indicated as possibly being associated with OB, were analyzed by combining the quantitative real time-polymerase chain reaction (qRT-PCR) and in situ hybridization (ISH) of lung tissues of OB affected patients. Disease and OB-lesion-specific expression of miR-21-5p was confirmed and by computational analysis we were able to identify the network of genes most probably associated miR-21-5p in the context of OB fibrogenesis. Among all potentially associated genes, STAT3 had a very high probability score. Immunohistochemistry showed that STAT3/miR-21-5p were co-over expressed in OB lesions, thus, suggesting miR-21-5p could regulate STAT3 expression. However, miR-21-5p inhibition in cultures of bronchiolitis obliterans syndrome (BOS) derived myofibroblasts did not significantly affect STAT3 mRNA and protein expression levels. This study demonstrates the specificity of miR-21-5p over-expression in OB lesions and contributes to existing knowledge on the miR-21-5p downstream pathway. Activation of STAT3 is associated with miR-21-5p upregulation, however, STAT-3 network activation is most likely complex and miR-21-5p is not the sole regulator of STAT3.

Identifiants

pubmed: 33804639
pii: cells10030688
doi: 10.3390/cells10030688
pmc: PMC8003603
pii:
doi:

Substances chimiques

MIRN21 microRNA, human 0
MicroRNAs 0
STAT3 Transcription Factor 0
STAT3 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Foundation IRCCS Policlinico San Matteo, Pavia, Italy (Ricerca corrente grant)
ID : 935-rcr2018i-30 and748-rcr2013-13
Organisme : Department of Molecular Medicine of the University of Pavia (young research funds)
ID : FRG 2017

Références

Mol Carcinog. 2017 Apr;56(4):1227-1238
pubmed: 27805284
Nanomedicine (Lond). 2015 Jan;10(1):9-23
pubmed: 24559038
Respir Res. 2016 Sep 05;17(1):110
pubmed: 27596748
Transl Res. 2011 Apr;157(4):191-9
pubmed: 21420029
Theranostics. 2017 Jun 1;7(8):2287-2288
pubmed: 28740551
Nat Commun. 2017 Oct 24;8(1):1130
pubmed: 29066712
J Cell Physiol. 2017 Nov;232(11):2938-2945
pubmed: 28112397
J Clin Invest. 2017 May 1;127(5):1786-1797
pubmed: 28375153
J Oncol. 2019 Nov 30;2019:4216750
pubmed: 31885576
J Thorac Dis. 2017 Aug;9(8):2650-2659
pubmed: 28932572
Chest. 2011 Aug;140(2):502-508
pubmed: 21813529
CNS Neurosci Ther. 2012 Sep;18(9):722-8
pubmed: 22709411
Mol Cell. 2010 Aug 27;39(4):493-506
pubmed: 20797623
J Cell Mol Med. 2014 Jun;18(6):991-1003
pubmed: 24702795
J Asthma. 2013 Nov;50(9):960-4
pubmed: 23822889
Transpl Immunol. 2017 Jun;42:1-4
pubmed: 28457921
Mol Cancer Res. 2007 May;5(5):509-20
pubmed: 17510316
Int J Mol Sci. 2018 Aug 05;19(8):
pubmed: 30081609
Rheumatology (Oxford). 2018 Oct 1;57(10):1838-1850
pubmed: 29029263
Biomed Res Int. 2014;2014:521586
pubmed: 24991558
Physiol Genomics. 2008 Apr 22;33(2):139-47
pubmed: 18303086
Respir Res. 2013 Sep 24;14:95
pubmed: 24063588
J Exp Med. 2010 Aug 2;207(8):1589-97
pubmed: 20643828
Proc Am Thorac Soc. 2012 Jul;9(3):177-82
pubmed: 22802294
Kidney Int. 2016 Dec;90(6):1285-1297
pubmed: 27616741
Mol Diagn Ther. 2018 Apr;22(2):157-168
pubmed: 29335927
Blood. 2007 Aug 15;110(4):1330-3
pubmed: 17496199
BMC Bioinformatics. 2016 Apr 08;17:157
pubmed: 27059647
Curr Transplant Rep. 2016 Sep;3(3):185-191
pubmed: 28090432
PLoS One. 2016 Aug 26;11(8):e0161771
pubmed: 27564214
Front Oncol. 2020 Sep 25;10:577636
pubmed: 33072610
FASEB J. 2016 Jan;30(1):129-40
pubmed: 26324850
Arthritis Res Ther. 2016 Jan 13;18:11
pubmed: 26762516
Toxicology. 2019 Feb 15;414:57-67
pubmed: 30658076
Toxicol Appl Pharmacol. 2013 Nov 15;273(1):27-34
pubmed: 24004609
Physiol Rev. 2017 Apr;97(2):529-552
pubmed: 28151425
J Heart Lung Transplant. 2010 Oct;29(10):1159-64
pubmed: 20580267
Sci Rep. 2018 Jul 24;8(1):11167
pubmed: 30042393
FASEB J. 2020 Dec;34(12):15647-15658
pubmed: 33058239
Mol Cancer. 2013 Jun 01;12:50
pubmed: 23725032
Respir Res. 2018 Feb 06;19(1):24
pubmed: 29409529
Fibrogenesis Tissue Repair. 2013 Aug 29;6(1):16
pubmed: 23987664
Bioinformatics. 2010 Nov 15;26(22):2924-6
pubmed: 20861032
J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):1-15
pubmed: 8820078

Auteurs

Sara Bozzini (S)

Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.

Laura Pandolfi (L)

Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.

Elena Rossi (E)

Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Medical Genetics Unit, IRCCS Mondino Foundation, 27100 Pavia, Italy.

Simona Inghilleri (S)

Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.

Michele Zorzetto (M)

Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.

Giuseppina Ferrario (G)

Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.

Stefano Di Carlo (S)

Control and Computer Engineer Department, Politecnico di Torino, 20129 Torino, Italy.

Gianfranco Politano (G)

Control and Computer Engineer Department, Politecnico di Torino, 20129 Torino, Italy.

Annalisa De Silvestri (A)

Clinical Epidemiology and Biometrics Unit, Foundation IRCCS Policlinico S. Matteo, 27100 Pavia, Italy.

Vanessa Frangipane (V)

Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.

Michele Porzio (M)

Service de Pneumologie, NouvelHôpital Civil, Hôpitaux Universitaires de Strasbourg, Fédération de Médecine Translationnelle (FMTS), 67085 Strasbourg, France.

Romain Kessler (R)

Service de Pneumologie, NouvelHôpital Civil, Hôpitaux Universitaires de Strasbourg, Fédération de Médecine Translationnelle (FMTS), 67085 Strasbourg, France.

Fiorella Calabrese (F)

Department of Cardiovascular and Thoracic Sciences, University of Padova, 35122 Padova, Italy.

Federica Meloni (F)

Research Laboratory of Lung Diseases, Section of Cell Biology, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.
Department of Internal Medicine, University of Pavia, 27100 Pavia, Italy.

Patrizia Morbini (P)

Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH